Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

GlaxoSmithKline plc (GSK)

39.46   0.12 (0.31%) 05-17 16:02
Open: 39.27 Pre. Close: 39.34
High: 39.68 Low: 39.27
Volume: 1,924,392 Market Cap: 100335M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 39.715 - 39.994 39.994 - 40.212
Low: 38.74 - 39.041 39.041 - 39.274
Close: 39.072 - 39.532 39.532 - 39.889

Technical analysis

as of: 2019-05-17 4:28:57 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 47.14     One year: 48.07
Support: Support1: 39.07    Support2: 32.51
Resistance: Resistance1: 40.36    Resistance2: 41.16
Pivot: 39.95
Moving Average: MA(5): 39.39     MA(20): 39.98
MA(100): 40.03     MA(250): 40.13
MACD: MACD(12,26): -0.35     Signal(9): -0.30
Stochastic oscillator: %K(14,3): 18.66     %D(3): 16.00
RSI: RSI(14): 40.75
52-week: High: 42.36  Low: 36.41  Change(%): -1.4
Average Vol(K): 3-Month: 240275  10-Days: 228766

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GSK has closed above bottom band by 29.4%. Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 May 2019 15:19:04 Z
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site

Wed, 08 May 2019 17:54:51 Z
Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates

Wed, 08 May 2019 15:51:13 Z
Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong

Tue, 07 May 2019 23:13:46 Z
What's in Store for Axsome (AXSM) This Earnings Season?

Mon, 06 May 2019 15:17:06 Z
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2493.89
Shares Float (M) 2493.89
% Held by Insiders
% Held by Institutions 12.60
Shares Short (K) 7588
Shares Short P. Month (K)

Stock Financials

EPS 3.070
EPS Est. Current Year 2.890
EPS Est. Next Year 2.850
EPS Est. Next Quarter
Forward EPS 2.930
Book Value (p.s.) 17.220
PEG Ratio 1.43
Profit Margin 13.67
Operating Margin
Return on Assets (ttm) 6.9
Return on Equity (ttm) -5658.0
Qtrly Rev. Growth 6.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 51.20
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 12.85
P/E Growth Ratio
P/BV 2.29

Dividends & Splits

Dividend 5.012
Dividend Yield 0.13
Dividend Pay Date 2019-07-11
Ex-Dividend Date 2019-05-16
Forward Dividend 2.390
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.